Mirae Asset Global Investments
ENVB icon

Mirae Asset Global Investments’s Enveric Biosciences ENVB Stock Holding History

Mirae Asset Global Investments’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32
Closed -$94K – 2408
2022
Q1 		$94K Sell
32
-12
-27% -$53K ﹤0.01% 1563
2021
Q4 		$365K Buy
+44
New +$618K ﹤0.01% 1483

Other funds holding ENVB

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global Investments's ENVB Position: Q2 2022 in Review

Mirae Asset Global Investments sold out of Enveric Biosciences (ENVB) in Q2 2022, closing a stake of 32 shares — an estimated $94K sold.

Mirae Asset Global Investments first reported a position in ENVB in Q4 2021 and held it in 2 quarters. The position peaked at $365K in Q4 2021. 21 funds tracked by Wall St. Rank hold ENVB as of Q2 2022.

  • Mirae Asset Global Investments reported no remaining Enveric Biosciences position as of Q2 2022 after selling out during the quarter.
  • Mirae Asset Global Investments sold 32 Enveric Biosciences shares in Q2 2022, an estimated $94K.
  • Mirae Asset Global Investments first reported a position in Enveric Biosciences in Q4 2021 and held it in 2 quarters.
  • Mirae Asset Global Investments's Enveric Biosciences position peaked at $365K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2022.

Based on Mirae Asset Global Investments's 13F filing for Q2 2022, filed 26 Jul 2022.